An efficient synthesis of sulfamides

Tetrahedron Letters

Volumn 51, Issue 21, 2010, Pages 2909-2913

  Guo, Chuangxing ^a   Dong, Liming ^a   Kephart, Susan ^a   Hou, Xinjun ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIDE; CHLORINE; DORIPENEM; FAMOTIDINE; FK 506 BINDING PROTEIN; JNJ 26990990; MACITENTAN; PROLINE; PYRIDINE; QUINAGOLIDE; SOLVENT; SULFAMIDE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CATALYST; COLUMN CHROMATOGRAPHY; DECOMPOSITION; DRUG STRUCTURE; DRUG SYNTHESIS; ENVIRONMENTAL TEMPERATURE; HEATING; HIGH TEMPERATURE; INHIBITION KINETICS; LOW TEMPERATURE;

EID: 77950930457     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetlet.2010.03.106     Document Type: Article

References (31)

1. 2NHCONHR.
2. Knieps, S.; Englert, H. C.; Gerlach, U.; Goegelein, H.; Heitsch, H. 'Piperidinesulfonylureas and Thioureas, Their Preparation, Their Use and Pharmaceutical Compositions Comprising Them' WO 2006/063722 A1.
3. Casini A., Winum J.-Y., Montero J.-L., Scozzafava A., and Supuran C.T. Bioorg. Med. Chem. Lett. 13 (2003) 837-840 10.1016/S0960-894X(03)00028-3
4. Park J.D., Kim D.H., Kim S.-J., and Woo J.-R. J. Med. Chem. 45 (2002) 5295 10.1021/jm020258v
5. Sparey T., Beher D., Best J., Biba M., Castro J.L., Clarke E., Hannam J., Harrison T., Lewis H., Madin A., Shearman M., Sohal B., Tsou N., Welch C., and Wrigley J. Bioorg. Med. Chem. Lett. 15 (2005) 4212-4216 10.1016/j.bmcl.2005.06.084
6. Benltifa M., Garcia Moreno M.I., Ortiz Mellet C., Garcia Fernandez J.M., and Wadouachi A. Bioorg. Med. Chem. Lett. 18 (2008) 2805 10.1016/j.bmcl.2008.04.004
7. Bender, J. A.; Ding, M.; Gentles, R. G.; Hewawasam, P. 'Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors', WO2009/067108 A1.
8. Muraglia E., Kinzel O., Gardelli C., Crescenzi B., Donghi M., Ferrara M., Nizi E., Orvieto F., Pescatore G., Laufer R., Gonzalez-Paz O., Di Marco A., Fiore F., Monteagudo E., Fonsi M., Felock P.J., Rowley M., and Summa V. J. Med. Chem. 51 (2008) 861 10.1021/jm701164t
9. Hulten J., Andersson H.O., Schaal W., Danielson H.U., Classon B., Kvarnstrom I., Karlen A., Unge T., Samulesson B., and Hallberg A. J. Med. Chem. 42 (1999) 4054-4061 10.1021/jm991054q
10. Manku S., Allan M., Nguyen N., Ajamian A., Rodrigue J., Therrien E., Wang J., Guo T., Rahil J., Petschner A.J., Nicolescu A., Lefebvre S., Li Z., Fournel M., Besterman J.M., Deziel R., and Wahhab A. Bioorg. Med. Chem. Lett. 19 (2009) 1866-1870 10.1016/j.bmcl.2009.02.075
11. Groutas W.C., Schechter N.M., He S., Yu H., Huan P., and Tu J. Bioorg. Med. Chem. Lett. 9 (1999) 2199-2204 10.1016/S0960-894X(99)00377-7
12. Zhong J., Gan X., Alliston K.R., and Groutas W.C. Bioorg. Med. Chem. 12 (2004) 589-593 10.1016/j.bmc.2003.10.059
13. Parrish C.A., et al. J. Med. Chem. 50 (2007) 4939 10.1021/jm070435y
14. Goldberg, J.; Fensome, A.; McComas, C. C.; Zhang, P. 'Substituted Benzothiadiazinedioxide Derivatives and Methods of Their Use' WO2008/073958 A2.
15. Patel S.D., Habeski W.M., Cheng A.C., de la Cruz E., Loh C., and Kablaoui N.M. Bioorg. Med. Chem. Lett. 19 (2009) 3339 10.1016/j.bmcl.2009.04.006
16. Lee K., Park C.W., Jung W.-H., Park H.D., Lee S.H., Chung K.H., Park S.K., Kwon O.H., Kang M., Park D.-H., Lee S.K., Kim E.E., Yoon S.K., and Kim A. J. Med. Chem. 46 (2003) 3612-3622 10.1021/jm030025j
17. Manfredi M.C., Bi Y., Nirschl A.A., Sutton J.C., Seethala R., Golla R., Beehler B.C., Sleph P.G., Grover G.J., Ostrowski J., and Hamann L.G. Bioorg. Med. Chem. Lett. 17 (2007) 4487 10.1016/j.bmcl.2007.06.007
18. Dow R.L., Paight E.S., Schneider S.R., Hadcock J.R., Hargrove D.M., Martin K.A., Maurer T.S., Mardone N.A., Tess D.A., and DaSilva-Jardine P. Bioorg. Med. Chem. Lett. 14 (2004) 3235 10.1016/j.bmcl.2004.03.089
19. Lee H.K., Bang M., and Pak C.S. Tetrahedron Lett. 46 (2005) 7139-7142 10.1016/j.tetlet.2005.08.092
20. Cheshire, D. R.; Cox, R. J.; Meghani, P. 'Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators' WO2006/024823 A1.
21. Parker M.H., Smith-Swintosky V.L., McComsey D.F., Huang Y., Brenneman D., Klein B., Malatynska E., White H.S., Milewski M., Herb M., Finley M.F.A., Liu Y., Lubin M.L., Qin N., Iannucci R., Leclercq L., Cuyckens F., Reitz A.B., and Maryanoff B.E. J. Med. Chem. 52 (2009) 7528-7536 doi:10.1021%2Fjm801432r
22. Human Phase III trial on-going according clinicaltrials.gov, http://clinicaltrials.gov/ct2/show/NCT00903331?term = Macitentan&rank = 1.
23. Cano C., Paez J.A., Goya P., Serrano A., Pavon J., Rodriguez de Fonseca F., Suardiaz M., and Martin M.I. Eur. J. Med. Chem. (2009) 4889 10.1016/j.ejmech.2009.08.003
24. Winum J.-Y., Toupet L., Barragan V., Dewynter G., and Montero J.-L. Org. Lett. 3 (2001) 2241 10.1021/ol0161312
25. Ducry L., Reinelt S., Seiler P., Diederich F., Bolin D.R., Campbell R.M., and Olson G.L. Helv. Chim. Acta 82 (1999) 2432 doi:10.1002/(SICI)1522-2675(19991215)82:12<2432::AID-HLCA2432>3.0.CO;2-H
26. Beaudoin S., Kinsey K.E., and Burns J.F. J. Org. Chem. 68 (2003) 115 10.1021/jo026505k
27. Preparation of various sulfamoyl chlorides have been previously reported in following patent publication. Guo, C.; Dong, L.; Hou, X.; Vanderpool, D. L.; Villafranca, J. E. PCT Int. Appl. WO 01/40185 A1, 2001.
28. 2 in deuterated DMSO) consistent with unlabeled product.
29. 15N-labeled product.
30. Nucleophilic addition to either ortho or para position of the pyridinium ring can lead to the same terminal sulfamide side product (21). Ortho addition is shown as an example in the proposed mechanism.
31. Synthetic procedure and analytical data of all compounds listed herein have been previously reported in following patent publication. Guo, C.; Dong, L.; Hou, X.; Vanderpool, D. L.; Villafranca, J. E. PCT Int. Appl. WO 01/40185 A1, 2001.